OPNT

Opiant Pharmaceuticals, Inc. Common Stock

Delisted

OPNT was delisted on the 1st of March, 2023.

0 hedge funds and large institutions have $0 invested in Opiant Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
-37
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
36
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Mariner
26
Mariner
Kansas
-$214K -10,550 Closed
GI
27
GAMCO Investors
Connecticut
-$203K -10,000 Closed
Osaic Holdings
28
Osaic Holdings
Arizona
-$111K -5,500 Closed
UBS Group
29
UBS Group
Switzerland
-$56.8K -2,802 Closed
LC
30
Lindbrook Capital
California
-$40.6K -2,000 Closed
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
-$24K -1,200 Closed
Bank of America
32
Bank of America
North Carolina
-$21.7K -1,070 Closed
TRCT
33
Tower Research Capital (TRC)
New York
-$15K -744 Closed
SWM
34
Spire Wealth Management
Virginia
-$10K -500 Closed
BWP
35
Baldwin Wealth Partners
Massachusetts
-$6.08K -300 Closed
FDCDDQ
36
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$3.65K -180 Closed